0:07
technology#coading Welcome to Code Clarity — your new destination for mastering programing languages, one question at a ...
2:30
S7 E4: Technicality or PMCPA Precedent for MSLs
A recent ruling (CASE/0549/04/25) found a MSL presenting at a promotional meeting no breach but why? Was it a technicality or a ...
2:57
S7 E2: "Every breath matters" - does that promote a specific medicine?
Rina & Jean discuss a recently published PMCPA ruling vs GSK (CASE/0709/08/25) about their corporate ad - placed before a ...
3:37
S7 E5: One event, three complaints & an easy fix
One third-party event, three pharma company sponsors & three complaints. All about the same thing - sponsorship declarations.
2:21
S7 E3: There's no such thing as a compliant venue
Rina & Jean discuss the criteria in determing if a meeting is compliant. Venue is only one!
5:05
S6 E1: Pharma Compliance 2026: Complaints, Trends and Wishful Thinking
Rina and Jean look ahead to UK pharma compliance in 2026, including likely complaint hotspots, familiar risk areas and the big ...
1:01
Welcome to Code Clarity – Your Gateway to Programming & Tech Mastery! Are you someone who wants to learn programming, ...
2:40
S7 E6: Scroll, like, breach...STOP!
No boring Code training: Rina & Jean summarise their webinar (free for subscribers) on Social Media Case ruling trends.
2:49
S7 E8: Signatory Standards Explained
Whether you are a new or seasoned signatory, the question of signatory standards is worth considering. Two experienced ...
3:09
Speakers confirmed, slides ready… but no one shows up. What do you do when a pharma meeting has no audience? Cancel?
3:07
S6 E4: What’s in the Package? PMCPA’s New Deal on Package Deals
The PMCPA has published 14 page guidance on Package Deals. We cut through the fluff and tell you what you need to know ...
2:52
Two PMCPA rulings (one old (2621/7/13), one recent(3900/5/24)) about an "innocent" drink but involving pharma customers.
6:19
S6 E3: Lavish by Name? Reading Between the Venue Lines
Can a venue name alone imply excess? Rina and Jean unpack a recent case (Case/0440/01/25) where a meeting held at a ...
5:03
Rina & Jean discuss a recent appeal by Janssen (Case AUTH/3825/9/23) relating to UK speakers presenting at international ...
5:12
S6 E2: Bottleneck to breakthrough: How AI is changing MLR approval
As MLR queues grow, complexity increases & review pain/boredom set in...there's good news for everyone! Rina & Jean are ...
2:20
Jean and Rina discuss a recent case about something said by a Celltrion sales rep - top tips relate to why it's important to prove ...
3:26
S6 E7: Global Voices, UK Rules: When Senior Leaders Speak to the Media
In this episode, Rina and Jean discuss what happens when senior global leaders speak about medicines in UK national media ...
3:00
20. Commercial package deals and alleged inducements to prescribe
Rina & Jean cover the recent ruling in Case AUTH/3701/10/22 (Astellas v Janssen) and discuss pharma providing nurse support, ...
3:12
Can a “views are my own” disclaimer really save you from the PMCPA's watchful eye? Spoiler: no. Moderna learns this the hard ...